Patient centricity

#Clinical trials #Drug delivery #Drug discovery #Patient centricity

Patient-centric clinical trials: Prescription for better health outcomes 

Kimberly Gentile​, Senior Vice President of Clinical Operations at Biohaven Pharmaceuticals, explores the importance of newer patient-centric clinical trial strategies that can help enable better outcomes.   Drug development is my passion. My 30-year career in the pharmaceutical industry has been spent on the frontline of clinical research. I love what… Read More

#Exclusive Content

Weighing scale
#Clinical trials #Obesity #Patient centricity

Overcoming challenges in obesity-related clinical trials 

Deirdre Albertson, Vice President, Project Management, Cardiovascular/Metabolic Division, ICON, Jack L Martin, MD, FACC, Senior Director, Cardiovascular Therapeutics, Drug Development Solutions, ICON and Simon Bruce, MD VP, Internal Medicine, Drug Development Solutions, ICON, assess the clinical trials landscape for obesity and ask why patient centricity is key to overcoming common… Read More

#Exclusive Content

Patient advocacy group
#Cancer #Cancer research #Clinical trial design #Clinical trials #Oncology #Patient centricity

Patient groups issue call to action on patient-centric clinical trials

A new whitepaper has introduced the concept of ‘cross-over’ options in cancer clinical trials, as a way to make trials more patient-centric in design. ‘Cross-over arms in oncology clinical trials: An important consideration for patients’ was published by the Cholangiocarcinoma Foundation (CCF) with the aim of… Read More

#News

Woman using mobile phone
#Citius Pharmaceuticals #Clinical trial #Patient centricity #Patient reported outcome

Patients report improvement in haemorrhoid treatment trial

Citius Pharmaceuticals has revealed positive results from its Phase IIb Study of Halo-Lido (CITI-002) for the treatment of haemorrhoids. The high dose formulation of CITI-002, a lidocaine and halobetasol combination formulation, provided a meaningful reduction in symptom severity, as reported by patients, when compared to individual… Read More

#News

Patient advocacy group
#Clinical trial design #Clinical trials #Decentralised clinical trials #Drug development #Patient centricity #Rare disease

Recruiting and retaining patients for successful drug development

Craig Stevens, Senior Patient Engagement Specialist, and Amanda Henkel, VP, Strategy from MEDiSTRAVA (an Inizio Company), delve into the challenges and opportunities that surround clinical trial design for rare diseases. The drug development process requires collaboration at all stages, and is particularly important in the rare disease setting, where in… Read More

#Exclusive Content

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Decentralised clinical trials #Patient centricity

Covid-related changes to clinical trials here to stay

The Covid-19 pandemic has led to improvements in clinical trial processes and a more technology-driven approach, a new report from Medidata has revealed. The report ‘European Industry Research Report: The Future of Clinical Trials’ includes insights from 400 clinical trial executives across the United Kingdom, France, Germany and Switzerland. The… Read More

#Covid-19 #News

#Clinical trials #Drug development #Opinion #Patient centricity #Public health

What can patients do to give input into clinical trial design? 

Business and profitability remain unquestionably important in the drug discovery community. However, the industry’s overarching goal of public health and the betterment of society have never been more apparent than in the aftermath of the pandemic and when observing the heights scientists reached through determination and collaboration in the fight… Read More

#Exclusive Content #Opinion

#Clinical trials #Patient centricity

Calls for life sciences to focus on patient centricity  

The life sciences and healthcare industries should restructure around patient centricity, according to global not-for-profit the Pistoia Alliance.   The call follows a meeting at the Pistoia Alliance’s annual European conference in London where discussions around the sector’s position in the wake of the Covid-19 pandemic took place. Read More

#News